INFLAMMATORY BOWEL DISEASE CLINICAL RESEARCH
SaludMax Medical Corp has proven solutions for inflammatory bowel disease trial challenges, including thorough site evaluation and selection based on precise metrics; careful recruitment and screening to confirm eligibility; frequent patient communication and education; intensive training of site personnel; and, if appropriate, electronic PROs using measures that are appropriate to specific disease entities.
Our IMID team has helped develop several biological therapies and also offers biosimilar experience. Over years of successful collaboration, SaludMax Medical Corp specialists have maintained close relationships with key opinion leaders, major academic institutions, and seasoned practitioners. These relationships plus extensive investigator networks in the optimal countries for IMID therapy development ensure highly effective, “made to measure” strategies.
SaludMax Medical Corp team of experts can guide you through regulatory requirements, development of complex study and protocol designs, and recruitment of eligible patients to implement the study protocol. Our team of therapeutic experts have extensive experience with global, pivotal IBD Phase I – IV studies across multiple indications.